Neuropsychiatric Issues in Parkinson's Disease

被引:51
作者
Cooney, Jeffrey W. [1 ]
Stacy, Mark [2 ]
机构
[1] Duke Univ, Sch Med, 932 Morreene Rd, Durham, NC 27705 USA
[2] Duke Univ, Sch Med, 120a Davison, Durham, NC 27705 USA
关键词
Parkinson's disease; Non-motor symptoms; Depression; Cognitive impairment; Psychosis; Impulse control disorders; IMPULSE CONTROL DISORDERS; DOPAMINE DYSREGULATION SYNDROME; DRUG-INDUCED PSYCHOSIS; DEEP BRAIN-STIMULATION; RANDOMIZED CONTROLLED-TRIAL; AGONIST WITHDRAWAL SYNDROME; MILD COGNITIVE IMPAIRMENT; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; VISUAL HALLUCINATIONS;
D O I
10.1007/s11910-016-0647-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cognitive and neuropsychiatric symptoms are common in Parkinson's Disease and may surpass motor symptoms as the major factors impacting patient quality of life. The symptoms may be broadly separated into those associated with the disease process and those that represent adverse effects of treatment. Symptoms attributed to the disease arise from pathologic changes within multiple brain regions and are not restricted to dysfunction in the dopaminergic system. Mood symptoms such as depression, anxiety, and apathy are common and may precede the development of motor symptoms by years, while other neuropsychiatric symptoms such as cognitive impairment, dementia, and psychosis are more common in later stages of the disease. Neuropsychiatric symptoms attributed to treatment include impulse control disorders, pathologic use of dopaminergic medications, and psychosis. This manuscript will review the current understanding of neuropsychiatric symptoms in Parkinson's Disease.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Neuropsychiatric symptoms in Parkinson's disease: aetiology, diagnosis and treatment
    Jones, Shoned
    Torsney, Kelli M.
    Scourfield, Lily
    Berryman, Katie
    Henderson, Emily J.
    BJPSYCH ADVANCES, 2020, 26 (06) : 333 - 342
  • [22] Sleep Issues in Parkinson's Disease and Their Management
    Zuzuarregui, Jose Rafael P.
    During, Emmanuel H.
    NEUROTHERAPEUTICS, 2020, 17 (04) : 1480 - 1494
  • [23] Neuropsychiatric Disorders in Parkinson's Disease: What Do We Know About the Role of Dopaminergic and Non-dopaminergic Systems?
    Dujardin, Kathy
    Sgambato, Veronique
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [24] Neuropsychiatric Complications of Parkinson Disease Treatments: Importance of Multidisciplinary Care
    Taylor, Jacob
    Anderson, William S.
    Brandt, Jason
    Mari, Zoltan
    Pontone, Gregory M.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2016, 24 (12) : 1171 - 1180
  • [25] New Clinical Trials for Nonmotor Manifestations of Parkinson's Disease
    Schrag, Anette
    Sauerbier, Anna
    Chaudhuri, Kallol Ray
    MOVEMENT DISORDERS, 2015, 30 (11) : 1490 - 1503
  • [27] Neuropsychiatric Treatments for Parkinson's Disease: Nonpharmacological Approaches
    Mathur, Neha
    Bhatt, Haseel
    Lidstone, Sarah C.
    SEMINARS IN NEUROLOGY, 2022, 42 (02) : 158 - 167
  • [28] Early Signs and Neuropsychiatric Symptoms in Parkinson's Disease
    Kasten, Meike
    Vollstedt, Eva-Juliane
    Klein, Christine
    ZEITSCHRIFT FUR NEUROPSYCHOLOGIE, 2014, 25 (01) : 31 - 38
  • [29] Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
    Seppi, Klaus
    Chaudhuri, K. Ray
    Coelho, Miguel
    Fox, Susan H.
    Katzenschlager, Regina
    Lloret, Santiago Perez
    Weintraub, Daniel
    Sampaio, Cristina
    Chahine, Lana
    Hametner, Eva-Maria
    Heim, Beatrice
    Lim, Shen-Yang
    Poewe, Werner
    Djamshidian-Tehrani, Atbin
    MOVEMENT DISORDERS, 2019, 34 (02) : 180 - 198
  • [30] The Implications of Parkinson's Disease for Women's Health
    Pretzer-Aboff, Ingrid
    Bunting-Perry, Lisette
    Spindler, Meredith
    JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING, 2016, 45 (05): : 723 - 736